BRCA1 and ovarian carcinoma: The overexpression of breast cancer suppressor protein 1 (BRCA1)-mediated HR was observed in cisplatin-resistant breast and ovarian carcinoma cell lines [115,116] as well as the occurrence of secondary BRCA1 mutations in breast cancers previously treated with platinum drugs [117].